ABSTRACT The municipality of Paracambi (Rio de Janeiro, Brazil) reports sporadic cases of American cutaneous leishmaniasis (ACL). Previous studies detected Nyssomyia intermedia (Diptera: Psychodidae) as the main vector in the region, but its spatial distribution and the presence of other vector species have not been evaluated. This study aims at filling this knowledge gap, by studying the ecology of sand flies, their spatiotemporal distribution, and correlation with land use/cover. Two campaigns of monthly sand fly collections using light traps and manual captures were conducted in 1992–1994 and 2001–2003. Females were dissected to detect natural Leishmania infections. The spatial distribution of sand flies was assessed using kernel density maps. Correlations with land use/cover were evaluated by extracting satellite imagery data around the capture points. A total of 17,232 sand flies from 13 species were captured. Medically important species included Ny. intermedia, Migonemyia migonei, Pintomyia fischeri and Ny. whitmani. No Leishmania-infected females were detected. Highest densities were detected in the peri-urban areas Cascata and Sabugo, and in rural areas São José and Mutirão. Ny. intermedia had statistically significant correlations with pasture and agricultural areas. Present results strengthened that Ny. intermedia and Mg. migonei are the main local ACL vectors. Correlations with land use evidence the association between ACL and anthropic environmental change.

Abstract INTRODUCTION: Favorable responses in American tegumentary leishmaniasis (ATL) patients to treatment with 5 mg Sbv/kg/day meglumine antimoniate (MA) has been reported in Rio de Janeiro, but little is known regarding the therapeutic response to low doses in patients from other locations. METHODS: A retrospective review of medical records was conducted to compare the therapeutic response to 5 mg Sbv/kg/day MA treatment among 36 patients who acquired ATL in Brazilian states other than Rio de Janeiro (OS group) and 72 patients from Rio de Janeiro (RJ group). RESULTS: One course of 5 mg Sbv/kg/day MA cured 72.8% of 81 cutaneous (CL) and 66.6% of 27 mucosal (ML) leishmaniasis-infected patients: 70% in the CL/RJ group, 81% in the CL/OS group, 50% in the ML/RJ group, and 80% in the ML/OS group. After up to two additional treatment courses at the same dose, 88.9% and 85.2% of the CL and ML patients were cured, respectively. Adverse events were observed in 40% of patients in the CL/RJ group, 57% of the CL/OS group, 58% of the ML/RJ group, and 80% of the ML/OS group. No significant differences were observed in the cure rates or adverse effects between the RJ and OS groups. No patients required permanent discontinuation of treatment due to adverse events. CONCLUSIONS: Patients with ATL acquired in both RJ and OS may respond to low-dose MA. While high-dose MA should remain the standard treatment for ATL, low-dose MA might be preferred when toxicity is a primary concern.

BACKGROUND American tegumentary leishmaniasis (ATL) is a non-lethal parasitic disease that presents with cutaneous (CL) and mucosal (ML) clinical forms. ATL treatment aims at healing the lesions and preventing the development of the late mucosal form. Systemic meglumine antimoniate (MA) therapy with 10-20 mg Sb5+/kg/day is the first choice of treatment. However, alternative therapies using 5 mg Sb5+/kg/day or intralesional (IL) MA are the usual regimens at the National Institute of Infectious Diseases (NIID), Rio de Janeiro, Brazil. OBJECTIVES To evaluate lethality and the incidence of relapse and development of late ML in CL patients treated at NIID from 2001 until 2013. METHODS Data were recovered from records of all ATL patients diagnosed during that period. FINDINGS Out of 777 patients, 753 were treated with MA (96.9%). Of those, 89.1% received alternative therapy of 9.9% IL and 79.2% systemic 5 mg Sb5+/kg/day. Some patients required 1-3 additional courses of treatment, thus making a total of 997 courses; 85.2% of them were subjected to alternative therapies. Lethality was 0.1%, relapse incidence 5.8%, and late ML incidence 0.25%. As a final outcome for the 777 patients, 95.9% were cured, 0.1% died and 4.0% were not able to follow-up. MAIN CONCLUSIONS Alternative MA schedules resulted in low lethality without increase of relapse or late ML incidence.

Abstract INTRODUCTION: Intralesional treatment for cutaneous leishmaniasis has been applied for over 30 years at the Oswaldo Cruz Foundation, Rio de Janeiro, with good therapeutic results and without relevant systemic toxicity. METHODS Meglumine antimoniate was injected subcutaneously, using a long medium-caliber needle (for example, 30mm × 0.8mm); patients received 1-3 injections, with 15-day intervals. RESULTS The technique is described in detail sufficient to enable replication. CONCLUSIONS: The treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate is a simple, effective, and safe technique, which may be used in basic healthcare settings.

Entre 1977 (caso índice) e 2006 foram confirmados 87 casos de leishmaniose visceral no Município do Rio de Janeiro, oriundos de áreas peri-urbanas das vertentes continentais e litorâneas do Maciço da Pedra Branca e das vertentes continentais do Maciço do Gericinó. A maioria (65,5%) dos pacientes tinha mais de 5 anos de idade, prevalecendo o sexo masculino (61,5%), sem diferença de freqüência entre os sexos até os 14 anos. A letalidade foi de 10,4%. Houve dois casos de co-infecção por leishmaniose visceral/vírus da imunodeficiência. Leishmania chagasi foi isolada de casos humanos e caninos. Presença de flebotomíneos associada a migrações humanas e caninas, ocupação desordenada degradando áreas de preservação ambiental e baixas condições socioeconômicas podem ter criado o contexto propício à instalação e à propagação da endemia. Vigilância epidemiológica estreita com as medidas tradicionais de controle e outras - busca ativa de pacientes, limpeza de terrenos e educação em saúde -, reduziram a incidência de casos humanos de 2,8 por 100 mil habitantes em 1981 para menos de 0,01 por 100 mil a partir de 1997. As taxas de infecção canina decresceram de 4,6% em 1984 para 1,6% em 2008. Lutzomyia longipalpis não foi detectada em algumas localidades onde ocorreram casos humanos e caninos. Em 2007 e 2008, nenhum novo caso da doença humana foi notificado, mas permanece uma preocupante prevalência sorológica residual canina.

From 1977 (index case) to 2006, 87 cases of visceral leishmaniasis were confirmed in the municipality of Rio de Janeiro, Brazil, in periurban areas on the continental and coastal slopes of the Pedra Branca massif and the continental slopes of the Gericinó massif. The majority (65.5%) of the patients were more than five years old, predominantly males (61.5%), but without any difference between the sexes below the age of 14 years. The overall fatality rate was 10.4%. Two cases of visceral leishmaniasis/human immunodeficiency virus coinfection were detected. Leishmania chagasi was isolated from human and canine cases. The associations between the presence of phlebotomines and human and canine migrations, disorderly occupation involving degradation of environmental preservation areas and poor socioeconomic conditions may have created a favorable setting for the establishment and propagation of the disease. Close epidemiological surveillance associated with traditional control measures and others (active case researches, land clearing and health education), reduced the incidence of human cases from 2.8 per 100,000 inhabitants in 1981 to less than 0.01 per 100,000 since 1997. The canine infection rates decreased from 4.6% in 1984 to 1.6% in 2008. Lutzomyia longipalpis was not detected in some locations where human and canine cases occurred. In the years 2007 and 2008, no new human cases were reported, but there is a persistent and worrisome residual canine seroprevalence.

Descrição de uma série retrospectiva de 151 casos de leishmaniose cutânea atendidos entre 1967 e 1982. Destes, 139 (92%) pacientes apresentavam lesões ativas e foram tratados com antimoniato de meglumina diariamente: 81 adultos receberam uma ampola de 5ml e 58 crianças receberam 1 a 5ml. Quarenta e cinco (32,4%) pacientes receberam tratamento antimonial contínuo durante 25 a 116 dias e 94 (67,6%) receberam tratamento intermitente com 2 a 5 séries de antimoniato de meglumina, cada uma delas com duração de 10 a 25 dias e cujos intervalos de descanso entre as séries variaram de 10 a 60 dias. A dose de antimônio, calculada retrospectivamente em 66 (47,5%) casos, variou entre 3,9 e 28,7mg Sb5+/kg/dia. Desses pacientes, 35 receberam >10mg e 31 receberam <10mg Sb5+/kg/dia. Não houve diferença significativa no tempo de cicatrização entre adultos e crianças, entre esquemas intermitentes e ininterrupto, nem entre doses altas e baixas. Entretanto, o tempo de cicatrização nas pernas e pés (67,5 dias) foi superior ao encontrado em outras localizações (48,7 dias) (p < 0,001). Cinqüenta e um pacientes foram reavaliados entre cinco e 14 anos após o tratamento e mantinham-se clinicamente curados. Essa série originou ensaios clínicos prospectivos utilizando doses baixas de antimônio no Rio de Janeiro.

We retrospectively analyzed a series of 151 cases of cutaneous leishmaniasis treated between 1967 and 1982. One-hundred-and-thirty-nine (92%) patients presented with active lesions and were treated with daily doses of meglumine antimoniate: 81 adults received a 5-ml vial IM and 58 children received 1 to 5ml. Forty-five (32.4%) patients underwent continuous treatment with meglumine antimoniate for 25 to 116 days without rest intervals, and 94 (67.6%) intermittent treatment with 2 to 5 series of meglumine antimoniate. Intermittent series could include schedules of daily IM applications for 10 to 25 days each and intervals varying from 10 to 60 days. Antimony dose was calculated for 66 (47.5%) patients and ranged from 3.9 to 28.7 Sb5+/kg/day. Of these, 35 patients received >10mg and 31 patients <10mg Sb5+/kg/day. Median time of healing was longer for lesions on the legs and feet - 67.5 days versus 48.7 days (p < 0.001) for other sites. However, there were no significant differences in the median time of healing between adults and children, intermittent and continuous regimens or high and low antimony doses. Fifty-one patients were reassessed 5 to 14 years after treatment and showed no evidence of disease. These results support further investigation (clinical trials) on treatment using low doses of antimony.

No município de Paracambi, Estado do Rio de Janeiro, foi realizado um inquérito epidemiológico sobre a leishmaniose tegumentar americana na população canina residente em áreas endêmicas rural e semiurbana. Foram cadastrados 179 cães e 138 (77,1%) foram examinados, segundo seus aspectos clínicos e desenvolvimento de hipersensibilidade tardia ao antígeno Imunoleish® e respostas sorológicas à reação de imunofluorescência indireta e ao ensaio imunoenzimático. Dos 9 (6,5.%) animais portadores de lesões/cicatrizes suspeitas, 66,7% foram causadas por Leishmania sp; 44,4% produziram infecção em hamsters e apresentaram crescimento em meio de cultura, compatíveis com o comportamento de Leishmania do complexo braziliensis. A caracterização molecular (análises isoenzimáticas e do perfil de restrição do KDNA) identificou 2 amostras como similares à Leishmania (Viannia) braziliensis. A prevalência da infecção canina observada através do teste cutâneo, RIFI e ELISA foi, respectivamente, 10,1%, 16,7% e 27,8%. A presença das formas clínica/subclínica da LTA na população canina associada à infecção humana sugere que o cão pode atuar como possível fonte de infecção, assim como na disseminação da doença.

In the district of Paracambi, State of Rio de Janeiro an epidemiological survey for American tegumentary leishmaniasis in canine population was carried out in endemic localities. A total of 179 dogs was registered and 138 (77.1%) examined for their clinical aspects, development of delayed hypersensitivity (DHS) with Imunoleish® antigen and serological responses by indirect immunofluorescent reaction and enzyme-linked immunosorbent assay. In 9 (6.5%) dogs with active cutaneous lesions or suspect scars, 66.7% were caused by Leishmania sp; 44.4% produced infection in hamsters and showed growth in culture media, which was considered to be compatible with the species of Leishmania braziliensis complex. The molecular characterization (isoenzyme and KDNA restriction profiles) defined two strains with similar profiles for L. (Viannia) braziliensis. The prevalence of canine infection estimated by the cutaneous test, IFR and ELISA was 10.1%, 16.7% and 27.8%, respectively. The presence of clinical / sub-clinical form of ATL in canine population associated with human infections suggested that the dog can act as source of infection as well as for dissemination of the disease.

Euthanasia of seropositive dogs has been one of the principal measures adopted by the Program for the Control of Leishmaniasis in Brazil for many years. However, its efficacy is currently being questioned. We obtained intact skin samples from 20 Leishmania-reactive dogs from the municipality of Rio de Janeiro that had been referred for euthanasia. The promastigote forms of Leishmania were isolated in culture from 18 of these animals. Fourteen of these isolates were identified as Leishmania (Leishmania) chagasi by isoenzyme electrophoresis; seven of these were from asymptomatic dogs and seven were from symptomatic animals with visceral leishmaniasis. In conclusion, cutaneous parasitism is found in the intact skin of dogs naturally infected with L. (L.) chagasi, irrespective of the presence or absence of clinical signs suggestive of visceral leishmaniasis.

O diagnóstico de esporotricose disseminada costuma ser obtido através da necrópsia e o isolamento de Sporothrix schenckii do sangue é raro. Fungemia foi demonstrada in vivo através do isolamento do S. schenckii do sangue periférico de 13 (n=38; 34,2%) gatos com esporotricose naturalmente adquirida. A coinfecção com FIV e com FeLV encontradas, respectivamente, em 6 (n=34; 17,6%) casos e 1 (n=34; 2,9%), aparentemente não alterou a freqüência do isolamento de S. schenckii do sangue periférico. Comparando estes resultados aos dos hemocultivos realizados simultaneamente houve concordância de 84,2%. Assim, propomos o cultivo do coágulo como um método alternativo prático, eficiente e econômico para o diagnóstico de esporotricose disseminada em gatos in vivo.

The diagnosis of disseminated sporotrichosis is usually obtained by necropsy and the isolation of Sporothrix schenckii from blood is rare. Fungemia was shown in vivo through the isolation of S. schenckii from peripheral blood of 13 (n=38, 34.2%) cats with naturally acquired sporotrichosis. The coinfection with FIV and with FeLV found, respectively, in 6 (n=34, 17.6%) cases and 1 (n=34, 2.9%), apparently did not alter the frequency of the isolation of S. schenckii from peripheral blood. There was agreement of 84.2% comparing these results to the blood culture results simultaneously achieved. In this way, we propose the clot culture as a practical alternative method, efficient and cheap for the diagnosis of disseminated sporotrichosis in cats in vivo.

Em 1977 foi diagnosticado o primeiro caso autóctone de leishmaniose visceral (LV) humano no Município do Rio de Janeiro. A partir de 1980, foram diagnosticados 54 casos autóctones em diversas localidades, sendo que desde 1993 ocorreram 17 casos humanos autóctones notificados. Oito deles ocorreram no bairro de Barra de Guaratiba e o restante distribuído pelos bairros: Camorim, Colônia, Grota Funda, Grumari, Ilha de Guaratiba e Carapiá. Entre setembro de 1996 a dezembro de 1999, foram realizadas capturas de flebotomíneos em 18 localidades nas encostas do maciço da Pedra Branca, no município, e coletados 18.303 espécimes com predomínio de L. intermedia (87,33%), L. migonei (6,59%), L. longipalpis (3,10%) e L. firmatoi (1,90%). A espécie L. longipalpis predominou em Barra de Guaratiba (46,80%), permanecendo ausente nas outras seis localidades onde também ocorreram casos de LV, o que sugere a participação de outras espécies tais como L. migonei e L. firmatoi, pertencentes ao mesmo grupo parafilético da espécie vetora, na cadeia de transmissão da LV na região.

The first autochthonous case of human visceral leishmaniasis (VL) in the Municipality of Rio de Janeiro was diagnosed in 1977. Since 1980, 54 autochthonous cases have been diagnosed in various locations, and since 1993 some 17 autochthonous human cases have been reported. Eight of these occurred in the neighborhood of Barra de Guaratiba and the others were distributed in the following neighborhoods: Camorim, Colônia, Grota Funda, Grumari, Ilha de Guaratiba, and Carapiá. From September 1996 to December 1999, phebotomine sandfly captures were performed at 18 sites on the mountainsides of the Pedra Branca Massif, in the Municipality, and a total of 18,303 specimens were collected, with a predominance of L. intermedia (87.33%), L. migonei (6.59%), L. longipalpis (3.10%), and L. firmatoi (1.90%). The species L. longipalpis predominated in Barra de Guaratiba (46.80%) and was absent from the other six locations where VL cases also occurred, suggesting the participation of other species like L. migonei and L. firmatoi, belonging to the same paraphyletic group of the vector species, in the VL transmission chain in the region.

Em 1977 foi diagnosticado o primeiro caso autóctone de leishmaniose visceral (LV) humano no Município do Rio de Janeiro. A partir de 1980, foram diagnosticados 54 casos autóctones em diversas localidades, sendo que desde 1993 ocorreram 17 casos humanos autóctones notificados. Oito deles ocorreram no bairro de Barra de Guaratiba e o restante distribuído pelos bairros: Camorim, Colônia, Grota Funda, Grumari, Ilha de Guaratiba e Carapiá. Entre setembro de 1996 a dezembro de 1999, foram realizadas capturas de flebotomíneos em 18 localidades nas encostas do maciço da Pedra Branca, no município, e coletados 18.303 espécimes com predomínio de L. intermedia (87,33%), L. migonei (6,59%), L. longipalpis (3,10%) e L. firmatoi (1,90%). A espécie L. longipalpis predominou em Barra de Guaratiba (46,80%), permanecendo ausente nas outras seis localidades onde também ocorreram casos de LV, o que sugere a participação de outras espécies tais como L. migonei e L. firmatoi, pertencentes ao mesmo grupo parafilético da espécie vetora, na cadeia de transmissão da LV na região.

The first autochthonous case of human visceral leishmaniasis (VL) in the Municipality of Rio de Janeiro was diagnosed in 1977. Since 1980, 54 autochthonous cases have been diagnosed in various locations, and since 1993 some 17 autochthonous human cases have been reported. Eight of these occurred in the neighborhood of Barra de Guaratiba and the others were distributed in the following neighborhoods: Camorim, Colônia, Grota Funda, Grumari, Ilha de Guaratiba, and Carapiá. From September 1996 to December 1999, phebotomine sandfly captures were performed at 18 sites on the mountainsides of the Pedra Branca Massif, in the Municipality, and a total of 18,303 specimens were collected, with a predominance of L. intermedia (87.33%), L. migonei (6.59%), L. longipalpis (3.10%), and L. firmatoi (1.90%). The species L. longipalpis predominated in Barra de Guaratiba (46.80%) and was absent from the other six locations where VL cases also occurred, suggesting the participation of other species like L. migonei and L. firmatoi, belonging to the same paraphyletic group of the vector species, in the VL transmission chain in the region.

É descrito pela primeira vez um caso de reação exantemática imediata e generalizada após teste de Montenegro com antígeno mertiolatado. A reação consistiu de eritema urticariforme generalizado associado a prurido. O prurido desapareceu na primeira hora após a medicação com brometazina por via oral e a erupção 12 horas após.

The authors describe for the first time a case of immediate and generalized reaction to Montenegro skin test with merthiolated antigen. This reaction consisted of generalized cutaneous rash with pruritus, and was treated with oral bromethazine. The pruritus disappeared an hour after medication and the rash 12 hours later.

Cutaneous biopsies (n = 94) obtained from 88 patients with American tegumentary leishmaniasis were studied by conventional and immunohistochemical techniques. Specimens were distributed as active lesions of cutaneous leishmaniasis (n = 53) (Group I), cicatricial lesions of cutaneous leishmaniasis (n = 35) (Group II) and suggestive scars of healed mucosal leishmaniasis patients (n = 6) (Group III). In addition, active cutaneous lesions of other etiology (n = 24) (Group C1) and cutaneous scars not related to leishmaniasis (n = 10) (Group C2) were also included in the protocol. Amastigotes in Group I biopsies were detected by routine histopathological exam (30.2%), imprint (28.2%), culture (43.4%), immunofluorescence (41.4%) and immunoperoxidase (58.5%) techniques; and by the five methods together (79.3%). In Group II, 5.7% of cultures were positive. Leishmanial antigen was also seen in the cytoplasm of macrophages and giant cells (cellular pattern), vessel walls (vascular pattern) and dermal nerves (neural pattern). Positive reaction was detected in 49 (92.5%), 20 (57%) and 4 (67%) biopsies of Groups I, II and III, respectively. Antigen persistency in cicatricial tissue may be related to immunoprotection or, on the contrary, to the development of late lesions. We suggest that the cellular, vascular and neural patterns could be applied in the immunodiagnosis of active and cicatricial lesions in which leishmaniasis is suspected.